{"gene":"IKBKG","run_date":"2026-06-10T01:55:22","timeline":{"discoveries":[{"year":1998,"finding":"IKK-gamma (NEMO) is an essential regulatory subunit of the IκB kinase complex, composed of similar amounts of IKK-alpha, IKK-beta, and two differentially processed forms of IKK-gamma. IKK-gamma interacts preferentially with IKK-beta and is required for activation of the IKK complex; a C-terminal truncation mutant that still binds IKK-beta acts as a dominant negative, blocking IKK and NF-κB activation.","method":"Purification to homogeneity by monoclonal antibody affinity, molecular cloning, dominant-negative truncation mutant assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — IKK complex purified to homogeneity, subunit identity confirmed by sequencing, functional requirement established by dominant-negative mutant; foundational paper widely replicated","pmids":["9751060"],"is_preprint":false},{"year":2000,"finding":"NEMO/IKKgamma is essential for NF-κB activation by proinflammatory cytokines in vivo; complete NEMO disruption causes male embryonic lethality due to massive hepatocyte apoptosis and completely blocks NF-κB activation, phenocopying incontinentia pigmenti in heterozygous females.","method":"Germline and conditional knockout mouse models, NF-κB activation assays, histology","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with defined molecular (NF-κB) and cellular (apoptosis, embryonic lethality) phenotypes, replicated in subsequent studies","pmids":["10911992"],"is_preprint":false},{"year":1999,"finding":"FIP-3/NEMO (identified as a 14.7K adenovirus-interacting protein) inhibits NF-κB by stabilizing IκB-α (blocking TNF-α-induced IκB-α phosphorylation and degradation) and binds RIP and NIK. Its N-terminal 119 amino acids mediate IKK-beta and IKK-alpha interactions; residues 201-300 mediate self-association and RIP interaction; and the C-terminal half mediates NF-κB inhibitory activity.","method":"Co-immunoprecipitation, deletion mutagenesis, IκB-α phosphorylation assay, NF-κB reporter assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain mapping by deletion mutants with multiple functional readouts in a single lab","pmids":["9927690"],"is_preprint":false},{"year":2000,"finding":"The N-terminal 119 amino acids of FIP3/NEMO mediate interaction with IKK-beta and IKK-alpha; the carboxy-terminal half contains the NF-κB inhibitory domain and blocks IκB-α phosphorylation/degradation; residues 201-300 constitute the self-association domain and FIP3-RIP interaction domain.","method":"Deletion mutant expression, co-immunoprecipitation, IκB-α phosphorylation assay, NF-κB reporter assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic domain mapping with multiple orthogonal functional readouts, single lab","pmids":["10734145"],"is_preprint":false},{"year":2002,"finding":"IKK-beta phosphorylates IKK-gamma/NEMO predominantly at serine 369 in the C-terminus (as well as sites in the central region) both in vitro and in vivo upon TNF-α and IL-1 stimulation; mutation of these C-terminal serines increases IKKgamma's ability to stimulate IKKbeta kinase activity, indicating feedback regulation.","method":"In vitro kinase assay, site-directed mutagenesis, in vivo phosphorylation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay combined with mutagenesis and in vivo validation, single lab but two orthogonal methods","pmids":["11971901"],"is_preprint":false},{"year":2003,"finding":"KSHV vFLIP binds IKK-gamma/NEMO at the central CCR3/4 region (amino acids 150-272) to activate the IKK complex; in KSHV-infected PEL cells, vFLIP co-elutes with an activated IKK complex (IKKalpha, IKKbeta, IKKgamma) and associates with the chaperone Hsp90, whose inhibition by geldanamycin blocks vFLIP-induced IKK activation.","method":"Yeast two-hybrid screen, bacterial/mammalian fragment expression, co-immunoprecipitation, mass spectrometry, gel filtration chromatography, Hsp90 inhibitor assay","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, mass spectrometry, domain mapping, and functional inhibitor studies across multiple orthogonal methods","pmids":["12890756"],"is_preprint":false},{"year":2009,"finding":"NEMO/IKKgamma has an NF-κB-independent antiapoptotic function: it prevents RIP1 from engaging caspase-8 at an early checkpoint prior to NF-κB-mediated transcription. In NEMO-deficient cells, RIP1 associates with caspase-8, causing rapid TNF-induced apoptosis independent of NF-κB status.","method":"NEMO-deficient cell lines, co-immunoprecipitation of RIP1-caspase-8 complex, NF-κB-independent rescue experiments","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with defined molecular interaction (RIP1-caspase-8 co-IP) and NF-κB independence demonstrated, single lab","pmids":["19373245"],"is_preprint":false},{"year":2009,"finding":"NEMO exists as a highly elongated dimer in solution that is in weak equilibrium with a tetrameric assembly. IKKbeta peptide binding disrupts tetramerization (mutually exclusive with IKK binding). NEMO binds linear di-ubiquitin with 1:1 stoichiometry per dimer (one di-ubiquitin per NEMO dimer), with a second weaker binding site apparent at higher concentrations.","method":"Hydrodynamic/biophysical analysis (sedimentation, gel filtration), isothermal titration calorimetry, stoichiometry determination","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — rigorous biophysical reconstitution with multiple hydrodynamic methods and quantitative binding measurements, single lab","pmids":["19422324"],"is_preprint":false},{"year":2010,"finding":"In the genotoxic stress pathway, ATM activates the IKK kinase TAK1 through NEMO/IKKgamma and ELKS (a protein rich in Glu/Leu/Lys/Ser). K63-linked polyubiquitination of ELKS (by XIAP/UBC13) enables ELKS association with TAK1 via TAB2/3; NEMO associates with ELKS through its ubiquitin-binding domain, assembling TAK1/TAB2/3 and NEMO/IKK complexes to activate NF-κB.","method":"Cell-based co-IP, ubiquitin-binding domain mutants, ELKS knockdown, reconstitution of complex assembly","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis and co-IP in multiple cell systems with defined ubiquitin-binding mutants, pathway ordering demonstrated","pmids":["20932476"],"is_preprint":false},{"year":2010,"finding":"BAG3 promotes survival by altering the interaction between Hsp70 and IKKgamma, increasing IKKgamma availability and protecting it from proteasome-dependent degradation, thereby increasing NF-κB activity.","method":"Co-immunoprecipitation, siRNA knockdown, xenograft tumor model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP showing BAG3-Hsp70-IKKgamma interaction with functional readout (NF-κB activity, proteasomal degradation), single lab","pmids":["20368414"],"is_preprint":false},{"year":2011,"finding":"In response to extensive DNA damage, ATM drives two sequential NF-κB activation phases both requiring NEMO/IKKgamma: the first induces TNF-α-TNFR1 feedforward signaling, promoting the second phase and driving RIP1 phosphorylation; RIP1 kinase then triggers JNK3-dependent IL-8 secretion and FADD-mediated caspase-8 activation, switching on cytokine production and apoptosis.","method":"Genetic knockdown/knockout of NEMO, ATM inhibition, sequential NF-κB activation assays, RIP1 phosphorylation analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with multiple pathway components, well-controlled sequential activation assays, published in high-impact journal with extensive mechanistic detail","pmids":["21458669"],"is_preprint":false},{"year":2012,"finding":"Src family protein tyrosine kinases (Src, Fyn, Lyn, Fgr) interact with and phosphorylate IKKgamma/NEMO at tyrosine 374 (Y374); Y374F mutation abrogates this phosphorylation and increases TNF-α-induced NF-κB activity. Additionally, KSHV vFLIP expression induces phosphorylation of serine 377 (S377); S377A mutation increases and S377E decreases NF-κB activity and IL-6 production, indicating negative feedback regulation.","method":"In vitro kinase assay, site-directed mutagenesis, mass spectrometry, NF-κB reporter assay, cytokine ELISA","journal":"mBio","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay, MS identification of sites, mutagenesis with functional NF-κB readout, single lab with multiple orthogonal methods","pmids":["23131831"],"is_preprint":false},{"year":2013,"finding":"TRAF6-mediated ubiquitination of NEMO requires the scaffold protein p62/sequestosome-1. p62 interacts with NEMO; siRNA depletion of p62 abrogates TRAF6-induced NEMO ubiquitination and severely impairs NF-κB activation following IL-1β stimulation.","method":"Co-immunoprecipitation, siRNA knockdown, ubiquitination assay, NF-κB activation assay","journal":"Molecular immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP plus functional siRNA knockdown with defined ubiquitination readout, single lab","pmids":["24270048"],"is_preprint":false},{"year":2014,"finding":"TNF and IL-1 stimulation induces rapid, transient recruitment of NEMO into punctate supramolecular structures at the cell periphery that are enriched in activated IKK and ubiquitinated NEMO, and colocalize with activated TNF receptors but not IL-1 receptors. IL-1 (but not TNF) requires K63-linked and LUBAC-generated linear ubiquitin chains to recruit NEMO into these structures.","method":"Live-cell fluorescence microscopy, super-resolution imaging, cells deficient in K63 ubiquitin or LUBAC components","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — live imaging with genetic cell systems deficient in specific ubiquitin linkages, multiple orthogonal approaches","pmids":["24446482"],"is_preprint":false},{"year":2015,"finding":"NEMO prevents hepatocarcinogenesis by inhibiting RIPK1 kinase activity-driven hepatocyte apoptosis through both NF-κB-dependent and NF-κB-independent functions. Combined RelA/c-Rel/RelB deletion did not phenocopy NEMO deficiency; knock-in of kinase-inactive RIPK1 prevented hepatocyte apoptosis and HCC; RIPK1 ablation induced TRADD-dependent apoptosis, revealing distinct kinase-dependent and scaffolding functions of RIPK1 downstream of NEMO.","method":"Conditional liver-specific KO mice, RIPK1 kinase-dead knock-in, genetic epistasis with triple NF-κB subunit deletion","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models with epistasis, conditional KO, and knock-in, rigorous dissection of NF-κB-dependent vs independent NEMO functions","pmids":["26555174"],"is_preprint":false},{"year":2016,"finding":"GSK-3β directly phosphorylates NEMO at serines 8, 17, 31, and 43 within its N-terminal domain and forms a complex with wild-type NEMO; point mutations at these serines abolish GSK-3β binding and phosphorylation, leading to NEMO destabilization but augmented K63-linked polyubiquitination and increased binding to IKKα and IKKβ, while impairing ordered TNF-α-induced NF-κB signaling.","method":"In vitro kinase assay, co-immunoprecipitation, site-directed mutagenesis, ubiquitination assay","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, single lab","pmids":["27929056"],"is_preprint":false},{"year":2017,"finding":"In the cGAS-STING pathway, cytosolic DNA activates TRIM32 and TRIM56 to synthesize ubiquitin chains that bind NEMO, which subsequently activates IKKβ (not IKKα). Activated IKKβ is required for TBK1 and NF-κB activation, and TBK1 reciprocally activates IKKβ, forming a positive feedback loop for robust cytokine production.","method":"Genetic knockouts (NEMO, IKKβ, TBK1), ubiquitin chain synthesis assays, NF-κB and IFN reporter assays","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic cell systems with multiple pathway components tested, single lab","pmids":["28939760"],"is_preprint":false},{"year":2017,"finding":"MAVS-mediated innate immune activation is partially dependent on NEMO: TRAFs' E3 ligase activity synthesizes ubiquitin chains that bind NEMO for NF-κB activation; NEMO-activated IKKα/β then phosphorylate TBK1/IKKε, linking the NEMO-dependent ubiquitin scaffold to TBK1/IKKε activation.","method":"TRAF quadruple KO cells, NEMO-deficient cells, ubiquitin chain binding assay, phosphorylation analysis","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO epistasis with pathway ordering, single lab","pmids":["29125880"],"is_preprint":false},{"year":2017,"finding":"Evidence for M1-linked polyubiquitin-mediated conformational change in NEMO: NEMO adopts a compact conformation (Dmax ~320 Å) rather than fully extended. A region (residues 112-150) in coiled-coil 1 inhibits di-ubiquitin binding to the CC2-LZ domain, and this auto-inhibition is overcome only by longer M1-linked (not K63-linked) polyubiquitin chains, suggesting allosteric activation.","method":"SEC-SAXS (size exclusion chromatography-small angle X-ray scattering), in vitro ubiquitin-binding assays with truncation mutants","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — structural method (SAXS) plus in vitro binding assays, single lab, conformational model supported but not fully validated by mutagenesis","pmids":["29111346"],"is_preprint":false},{"year":2018,"finding":"TRIM37 monoubiquitinates NEMO at K309 in the nucleus in response to genotoxic stress (ATM-phosphorylated TRIM37 translocates to the nucleus); this monoubiquitination triggers nuclear export of NEMO and subsequent IKK/NF-κB activation. The ATM/TRIM37/NEMO nuclear-to-cytoplasmic axis mediates genotoxic NF-κB activation.","method":"Co-immunoprecipitation, ubiquitination assay with K309 mutant, nuclear fractionation, cell-penetrating inhibitor peptide, in vivo xenograft","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP, site-specific ubiquitination assay, nuclear fractionation with functional readout, single lab","pmids":["30254148"],"is_preprint":false},{"year":2019,"finding":"The IKKβ-binding domain of NEMO forms an irregular coiled coil with a dynamic interface: the unbound structure adopts a closed conformation that partially occludes three binding hot-spots and can transition to an open state for ligand binding.","method":"X-ray crystallography of unbound NEMO IKKβ-binding domain, fusion protein engineering","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure of NEMO domain with functional inference, single lab","pmids":["30814588"],"is_preprint":false},{"year":2019,"finding":"PAD4 preferentially citrullinates IKKgamma/NEMO (over IKKα or IKKβ), and this citrullination promotes NF-κB activation via IκBα phosphorylation in renal proximal tubular cells. NEMO citrullination by PAD4 contributes to ischemia-reperfusion-induced NF-κB activation and acute kidney injury.","method":"In vitro citrullination assay with recombinant proteins, IκBα phosphorylation assay, NEMO-binding peptide inhibition, in vivo ischemia-reperfusion model","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro reconstitution with recombinant proteins, functional cell-based validation, single lab","pmids":["30943066"],"is_preprint":false},{"year":2019,"finding":"Murine cytomegalovirus M45 protein induces aggregation and selective autophagy of NEMO (and RIPK1) as an immune evasion mechanism. M45 contains an 'induced protein aggregation motif' that triggers NEMO sequestration into insoluble aggregates, followed by recruitment of VPS26B and LC3-interacting adaptor TBC1D5 to degrade aggregates by selective autophagy (aggrephagy).","method":"Protein aggregation assays, autophagy flux assays, mutant M45 analysis, co-immunoprecipitation","journal":"Nature microbiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined protein motif with functional consequence, multiple viral orthologs tested, single primary model system","pmids":["31844296"],"is_preprint":false},{"year":2020,"finding":"DNA-PK phosphorylates NEMO at serine 43, enabling its nuclear entry (SUMOylation) and subsequent nucleocytoplasmic shuttling for NF-κB activation in response to genotoxic stress. DNA-PK knockdown or S43A point mutation blocks NEMO nuclear entry and abolishes ionizing radiation-induced NF-κB activation.","method":"Site-directed mutagenesis (S43A), shRNA knockdown of DNA-PKcs, nuclear fractionation, SUMOylation assay, NF-κB activation assay","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis plus genetic knockdown with nuclear fractionation, single lab","pmids":["31932854"],"is_preprint":false},{"year":2020,"finding":"MARCH2 is a novel E3 ubiquitin ligase that negatively regulates NEMO by directly interacting with NEMO during the late phase of infection and catalyzing K48-linked ubiquitination of Lys326 on NEMO, leading to its proteasomal degradation and dampening innate immune responses.","method":"Co-immunoprecipitation, in vitro ubiquitination assay, site-directed mutagenesis (K326), MARCH2 knockout mice","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct interaction demonstrated by co-IP, site-specific ubiquitination mapped by mutagenesis, in vivo KO validation with infectious phenotype","pmids":["32935379"],"is_preprint":false},{"year":2021,"finding":"N4BP1 inhibits TLR-dependent NF-κB activation by directly binding NEMO to attenuate NEMO-NEMO dimerization/oligomerization. The UBA-like and CUE-like domains of N4BP1 interact with the NEMO COZI domain. TRIF-activated caspase-8 cleaves N4BP1 to abolish its inhibitory effect, selectively enabling TLR4/TLR3-mediated NF-κB signaling.","method":"Co-immunoprecipitation, domain mapping, N4bp1 knockout mice, in vitro binding assay, caspase-8 cleavage assay","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, domain mapping, in vitro binding, KO mice with in vivo phenotype, caspase cleavage mechanism","pmids":["33654074"],"is_preprint":false},{"year":2022,"finding":"Polyubiquitin chains (K63-linked or linear/M1-linked) binding to NEMO robustly induce liquid-liquid phase separation of NEMO into droplets in which IKK is activated. Both the NUB domain and zinc-finger domain of NEMO contribute to polyUb binding and phase separation. NEMO mutations associated with human immunodeficiency impair phase separation. NEMO phase separation is required for IKK and NF-κB activation.","method":"In vitro reconstitution of phase separation with purified proteins, cell-based phase separation assay, disease-associated mutant analysis, IKK activation assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of phase separation with purified components, cell-based validation, domain mutants, disease mutants tested; multiple orthogonal methods","pmids":["35477005"],"is_preprint":false},{"year":2022,"finding":"A NEMO isoform lacking exon 5 (NEMO-Δex5) fails to associate with TBK1, impairing TLR3/RIG-I responses but not TNF-induced NF-κB. In immune cells expressing NEMO-Δex5, the inducible IKK protein (IKKi) is stabilized by NEMO-Δex5, promoting type I IFN induction. This establishes exon 5 as required for TBK1 association and regulation of the IFN response.","method":"Patient-derived cells, co-immunoprecipitation of NEMO-Δex5 with TBK1, TLR3/RIG-I vs TNF stimulation assays, IKKi stabilization assay","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — patient cell-based co-IP, isoform functional dissection, single lab","pmids":["35289316"],"is_preprint":false},{"year":2023,"finding":"NEMO is recruited to damaged mitochondria in a Parkin-dependent manner, where it partitions into phase-separated condensates colocalizing with p62. Recruitment of NEMO to damaged mitochondria brings active phospho-IKKβ, initiating NF-κB signaling and upregulation of inflammatory cytokines. This occurs in parallel with mitophagy as a damage-sensing platform.","method":"Live-cell fluorescence imaging, FRAP, Parkin knockout validation, fractionation, IKKβ phosphorylation assay","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization by live imaging, genetic (Parkin KO) requirement, IKKβ recruitment with functional NF-κB readout, multiple orthogonal methods","pmids":["37683611"],"is_preprint":false},{"year":2023,"finding":"NEMO promotes autophagosomal clearance of protein aggregates in an NF-κB-independent manner. NEMO amplifies linear ubiquitylation at α-synuclein aggregates and promotes local concentration of p62 into foci. In vitro, NEMO lowers the threshold concentration required for ubiquitin-dependent phase transition of p62, reshaping the aggregate surface for efficient autophagic clearance.","method":"In vitro phase separation reconstitution, patient cell analysis, co-condensation assays with p62 and ubiquitin","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro reconstitution of phase transition plus patient cell validation, single lab, novel NF-κB-independent function","pmids":["38114471"],"is_preprint":false},{"year":2023,"finding":"M1-linked (linear) ubiquitin chains induce phase separation of NEMO and formation of NEMO assemblies in cells after IL-1β stimulation. Phase separation is driven by both non-covalent NEMO binding to linear ubiquitin chains and covalent linkage of M1-ubiquitin to NEMO; a pathogenic NEMO mutant defective in both binding and covalent linkage to linear ubiquitin does not undergo phase separation and is defective in IL-1β-induced NF-κB activation.","method":"In vitro phase separation assay, cell-based condensate formation, disease mutant analysis, NF-κB reporter assay","journal":"Life science alliance","confidence":"Medium","confidence_rationale":"Tier 1-2 / Moderate — in vitro reconstitution and cell-based validation, disease mutant mechanistic insight, single lab","pmids":["36720498"],"is_preprint":false},{"year":2019,"finding":"SENP1-mediated de-SUMOylation of NEMO inhibits NF-κB activation in intermittent hypoxia-challenged microglia. Intermittent hypoxia enhances NEMO SUMOylation; overexpression of SENP1 decreases NEMO SUMOylation and suppresses NF-κB activation and proinflammatory cytokine production.","method":"Co-immunoprecipitation for SUMOylation, SENP1 overexpression, NF-κB reporter assay, cytokine ELISA","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP for SUMOylation with functional readout, single lab","pmids":["31549402"],"is_preprint":false},{"year":2008,"finding":"High-affinity interaction between IKKβ and NEMO requires a longer C-terminal region of IKKβ beyond the minimal NBD peptide. The longer IKKβ C-terminal region forms a 2:2 stoichiometric complex with NEMO, as measured by surface plasmon resonance, ITC, and MALS.","method":"Surface plasmon resonance, isothermal titration calorimetry, multiangle light scattering","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — quantitative biophysical reconstitution with three orthogonal methods, single lab","pmids":["18266324"],"is_preprint":false}],"current_model":"NEMO/IKKgamma (IKBKG) is the essential regulatory/scaffold subunit of the IκB kinase complex that binds preferentially to IKKβ (and IKKα) through its N-terminal region and integrates upstream signals—primarily non-degradative K63-linked and M1-linked polyubiquitin chains—via its NUB and zinc-finger domains to promote IKK activation through liquid-liquid phase separation; NEMO undergoes extensive post-translational regulation (phosphorylation by IKKβ, GSK-3β, DNA-PK, and Src-family kinases; K63-linked ubiquitination by TRAF6/p62; K48-linked ubiquitination for degradation by MARCH2; monoubiquitination at K309 by TRIM37; SUMOylation/de-SUMOylation) that modulates its activity, localization, and stability; it shuttles between cytoplasm and nucleus in response to DNA damage (ATM/DNA-PK-dependent), serves an NF-κB-independent antiapoptotic function by restraining RIP1 from engaging caspase-8, is recruited to damaged ubiquitinated mitochondria in a Parkin-dependent manner to initiate NF-κB signaling, and promotes autophagosomal clearance of protein aggregates independently of NF-κB by co-condensing with p62."},"narrative":{"mechanistic_narrative":"IKBKG (NEMO/IKKγ) is the essential non-catalytic regulatory subunit of the IκB kinase complex and the central scaffold that couples upstream signals to NF-κB activation [PMID:9751060, PMID:10911992]. Through its N-terminal region it binds preferentially to IKKβ (and IKKα), forming a defined high-affinity 2:2 complex, and its loss completely blocks cytokine-induced NF-κB activation, causing embryonic lethality from massive hepatocyte apoptosis and phenocopying incontinentia pigmenti in heterozygous females [PMID:10911992, PMID:18266324]. NEMO functions as a ubiquitin sensor: K63-linked and M1/linear polyubiquitin chains, generated by upstream E3 ligases, engage its NUB and zinc-finger domains and drive its assembly into liquid-liquid phase-separated condensates within which IKK is activated, with disease-associated NEMO mutations impairing both ubiquitin engagement and phase separation [PMID:35477005, PMID:36720498, PMID:29111346]. This ubiquitin-scaffold logic operates across diverse inputs—TNF and IL-1 receptor signaling [PMID:24446482], genotoxic stress via ATM [PMID:21458669], and cytosolic nucleic-acid sensing through cGAS-STING and MAVS [PMID:28939760, PMID:29125880]. NEMO activity is tuned by extensive post-translational modification, including feedback phosphorylation by IKKβ, GSK-3β, DNA-PK and Src-family kinases, K63-linked ubiquitination requiring p62/TRAF6, K48-linked degradative ubiquitination by MARCH2, and SUMOylation [PMID:11971901, PMID:23131831, PMID:27929056, PMID:31932854, PMID:24270048, PMID:32935379, PMID:31549402]. Beyond transcription, NEMO carries an NF-κB-independent antiapoptotic role, restraining RIPK1 from engaging caspase-8 and thereby preventing hepatocyte death and hepatocarcinogenesis [PMID:19373245, PMID:26555174], is recruited to Parkin-marked damaged mitochondria to initiate inflammatory signaling [PMID:37683611], and co-condenses with p62 to promote autophagic clearance of protein aggregates independently of NF-κB [PMID:38114471].","teleology":[{"year":1998,"claim":"Established that the IKK complex contains an essential regulatory subunit distinct from its catalytic kinases, defining NEMO as required for IKK/NF-κB activation.","evidence":"Antibody affinity purification of the IKK complex to homogeneity, cloning, and dominant-negative truncation mutants","pmids":["9751060"],"confidence":"High","gaps":["Did not define how upstream signals engage the subunit","No structural basis for IKKβ binding"]},{"year":1999,"claim":"Mapped NEMO's modular architecture, assigning IKK binding to the N-terminus, self-association/RIP interaction to a central region, and NF-κB regulatory activity to the C-terminus.","evidence":"Co-IP and deletion mutagenesis with IκBα phosphorylation and NF-κB reporter readouts","pmids":["9927690","10734145"],"confidence":"Medium","gaps":["Domain boundaries inferred from deletions, not structure","Single-lab functional readouts"]},{"year":2000,"claim":"Demonstrated in vivo that NEMO is indispensable for cytokine-induced NF-κB, linking its loss to hepatocyte apoptosis and human incontinentia pigmenti.","evidence":"Germline and conditional NEMO knockout mice with NF-κB assays and histology","pmids":["10911992"],"confidence":"High","gaps":["Did not separate scaffold from ubiquitin-sensing functions","Mechanism of apoptosis protection unresolved at this stage"]},{"year":2002,"claim":"Identified NEMO as a substrate of its own complex, revealing IKKβ-mediated C-terminal phosphorylation as a negative feedback control on IKK activity.","evidence":"In vitro and in vivo kinase assays with site-directed mutagenesis (S369)","pmids":["11971901"],"confidence":"High","gaps":["Physiological kinetics of feedback not quantified","Other modifying kinases not yet identified"]},{"year":2008,"claim":"Defined the stoichiometry and affinity determinants of the core IKKβ-NEMO interaction, showing a 2:2 complex requiring more than the minimal NBD peptide.","evidence":"SPR, ITC, and MALS biophysical reconstitution","pmids":["18266324"],"confidence":"High","gaps":["No full-length complex structure","Conformational dynamics of binding not addressed"]},{"year":2009,"claim":"Revealed NEMO's solution architecture and ubiquitin-binding behavior, showing an elongated dimer that binds linear di-ubiquitin and whose tetramerization is mutually exclusive with IKK binding.","evidence":"Hydrodynamic analysis and ITC stoichiometry measurements","pmids":["19422324"],"confidence":"High","gaps":["Functional consequence of tetramer in cells unclear","Did not address longer/branched ubiquitin chains"]},{"year":2009,"claim":"Uncovered an NF-κB-independent survival function in which NEMO blocks RIP1-caspase-8 association at an early checkpoint.","evidence":"NEMO-deficient cells with RIP1-caspase-8 co-IP and NF-κB-independent rescue","pmids":["19373245"],"confidence":"Medium","gaps":["Molecular basis of RIP1 restraint not defined","Single-lab finding"]},{"year":2010,"claim":"Connected NEMO to genotoxic-stress NF-κB activation through ubiquitin-dependent assembly of TAK1 and IKK complexes via ELKS.","evidence":"Cell-based co-IP, ubiquitin-binding-domain mutants, and ELKS knockdown","pmids":["20932476"],"confidence":"High","gaps":["In vitro reconstitution of the assembly not shown","Quantitative ubiquitin chain requirements unresolved"]},{"year":2010,"claim":"Showed NEMO abundance is set by chaperone-dependent stability control, with BAG3 modulating Hsp70-NEMO interaction to protect NEMO from proteasomal degradation.","evidence":"Co-IP, siRNA knockdown, and xenograft tumor model","pmids":["20368414"],"confidence":"Medium","gaps":["Direct vs indirect chaperone effect not separated","Single-lab finding"]},{"year":2011,"claim":"Placed NEMO at the head of a biphasic ATM-driven NF-κB program that toggles between cytokine production and apoptosis after DNA damage.","evidence":"Genetic NEMO/ATM perturbation with sequential NF-κB and RIP1 phosphorylation assays","pmids":["21458669"],"confidence":"High","gaps":["Mechanism of NEMO nuclear involvement not yet defined here","Cell-type generality unclear"]},{"year":2012,"claim":"Expanded the phospho-regulatory code, identifying Src-family tyrosine phosphorylation (Y374) and vFLIP-induced S377 phosphorylation as feedback brakes on NF-κB.","evidence":"In vitro kinase assays, MS site mapping, mutagenesis, and NF-κB/cytokine readouts","pmids":["23131831"],"confidence":"High","gaps":["Physiological stimuli engaging Src kinases on NEMO unclear","Crosstalk with other PTMs not addressed"]},{"year":2013,"claim":"Established that p62/sequestosome-1 is required for TRAF6-mediated K63 ubiquitination of NEMO downstream of IL-1β.","evidence":"Co-IP, siRNA knockdown, ubiquitination and NF-κB activation assays","pmids":["24270048"],"confidence":"Medium","gaps":["Direct vs scaffolded ubiquitination not distinguished","Single-lab finding"]},{"year":2014,"claim":"Visualized stimulus-specific recruitment of NEMO into ubiquitin-dependent peripheral supramolecular structures, distinguishing TNF from IL-1 ubiquitin requirements.","evidence":"Live-cell and super-resolution imaging in K63/LUBAC-deficient cells","pmids":["24446482"],"confidence":"High","gaps":["Material state of structures not defined at this stage","Spatial relationship to receptor not fully resolved for IL-1"]},{"year":2015,"claim":"Dissected the dual NF-κB-dependent and -independent NEMO functions that suppress RIPK1 kinase-driven hepatocyte apoptosis and hepatocarcinogenesis.","evidence":"Liver-specific conditional KO, RIPK1 kinase-dead knock-in, and triple NF-κB subunit deletion epistasis","pmids":["26555174"],"confidence":"High","gaps":["Molecular basis of the NF-κB-independent activity not biochemically defined","How NEMO restrains RIPK1 kinase activity unclear"]},{"year":2016,"claim":"Identified GSK-3β as an N-terminal NEMO kinase whose phosphorylation stabilizes NEMO and orders TNF-α-induced NF-κB signaling.","evidence":"In vitro kinase assay, co-IP, mutagenesis, and ubiquitination assay","pmids":["27929056"],"confidence":"Medium","gaps":["In vivo relevance not established","Single-lab finding"]},{"year":2017,"claim":"Positioned NEMO as a ubiquitin-sensing hub in cytosolic nucleic-acid immunity, linking cGAS-STING and MAVS to IKKβ and reciprocal TBK1 activation.","evidence":"Genetic KO epistasis with ubiquitin chain synthesis/binding and reporter assays","pmids":["28939760","29125880"],"confidence":"Medium","gaps":["Identity of physiological ubiquitin ligases in each pathway not fully resolved","Single-lab findings"]},{"year":2017,"claim":"Provided a structural rationale for chain-length-selective activation, showing NEMO is autoinhibited and preferentially activated by longer M1-linked over K63-linked chains.","evidence":"SEC-SAXS with truncation-mutant ubiquitin-binding assays","pmids":["29111346"],"confidence":"Medium","gaps":["Conformational model not validated by full mutagenesis","Atomic-resolution structure of activated state lacking"]},{"year":2018,"claim":"Defined a nuclear-to-cytoplasmic NEMO relay in genotoxic signaling via TRIM37 monoubiquitination at K309 driving nuclear export.","evidence":"Co-IP, K309 ubiquitination mutant, nuclear fractionation, inhibitor peptide, and xenograft","pmids":["30254148"],"confidence":"Medium","gaps":["Export machinery reading the monoubiquitin mark not identified","Single-lab finding"]},{"year":2019,"claim":"Resolved the IKKβ-binding domain structure, revealing a dynamic closed-to-open conformational switch governing ligand engagement.","evidence":"X-ray crystallography of the unbound NEMO IKKβ-binding domain","pmids":["30814588"],"confidence":"High","gaps":["Open state not captured structurally","Coupling to full-length activation untested"]},{"year":2019,"claim":"Added citrullination (by PAD4) and SUMOylation control (by SENP1) to the NEMO modification repertoire with disease-relevant functional consequences.","evidence":"In vitro citrullination/SUMOylation assays, SENP1 overexpression, and in vivo injury models","pmids":["30943066","31549402"],"confidence":"Medium","gaps":["Modified residues and their structural effects partly undefined","Single-lab findings"]},{"year":2019,"claim":"Revealed viral subversion of NEMO via induced aggregation and selective autophagy, establishing aggrephagy of NEMO as an immune-evasion route.","evidence":"Protein aggregation and autophagy flux assays with M45 mutants and co-IP","pmids":["31844296"],"confidence":"Medium","gaps":["Host adaptor recruitment hierarchy partly inferred","Generality beyond viral context untested"]},{"year":2020,"claim":"Showed DNA-PK phosphorylation of NEMO at S43 licenses its nuclear entry and shuttling for genotoxic NF-κB activation.","evidence":"S43A mutagenesis, DNA-PKcs knockdown, nuclear fractionation, and SUMOylation/NF-κB assays","pmids":["31932854"],"confidence":"Medium","gaps":["Integration with ATM/TRIM37 axis not reconciled","Single-lab finding"]},{"year":2020,"claim":"Identified MARCH2 as an E3 ligase that degrades NEMO via K48-linked ubiquitination at K326 to dampen innate immune responses.","evidence":"Co-IP, in vitro ubiquitination, K326 mutagenesis, and MARCH2 knockout mice","pmids":["32935379"],"confidence":"High","gaps":["Temporal trigger for late-phase MARCH2 engagement unclear","Substrate selectivity determinants not defined"]},{"year":2021,"claim":"Defined a negative regulator that blocks NEMO oligomerization, with N4BP1 binding the COZI domain and caspase-8 cleavage relieving inhibition during TLR signaling.","evidence":"Co-IP, domain mapping, in vitro binding, caspase-8 cleavage, and N4bp1 KO mice","pmids":["33654074"],"confidence":"High","gaps":["Structural basis of dimerization blockade not solved","Breadth across TLR/receptor inputs not fully mapped"]},{"year":2022,"claim":"Unified the ubiquitin-sensing model by showing polyubiquitin chains drive NEMO liquid-liquid phase separation that is required for IKK/NF-κB activation and impaired by disease mutations.","evidence":"In vitro reconstitution with purified proteins, cell-based phase separation, and disease/domain mutant analysis","pmids":["35477005","36720498"],"confidence":"High","gaps":["Quantitative link between condensate properties and IKK output incomplete","In vivo relevance of condensates not demonstrated"]},{"year":2022,"claim":"Demonstrated isoform-specific signal routing, showing exon 5 is required for NEMO-TBK1 association and proper type I IFN versus NF-κB partitioning.","evidence":"Patient-derived cells, NEMO-Δex5 co-IP with TBK1, and pathway-selective stimulation assays","pmids":["35289316"],"confidence":"Medium","gaps":["Structural basis of exon-5-dependent TBK1 binding unknown","Single-lab patient-derived system"]},{"year":2023,"claim":"Extended NEMO function beyond canonical signaling to organelle damage sensing and protein quality control, via Parkin-dependent recruitment to mitochondria and p62 co-condensation for aggregate autophagy.","evidence":"Live imaging, FRAP, Parkin KO, in vitro phase transition reconstitution, and patient cell analysis","pmids":["37683611","38114471"],"confidence":"High","gaps":["Signal that recruits NEMO to mitochondria/aggregates not fully defined","Relative contribution of NF-κB-independent roles in vivo unclear"]},{"year":null,"claim":"How the diverse NEMO post-translational modifications, conformational states, and condensate properties are integrated to set quantitative IKK output across distinct receptor inputs remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No atomic structure of the activated, ubiquitin-engaged full-length complex","No unified quantitative model linking PTM combinations to signaling outcome","In vivo relevance of phase separation not directly tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,4]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,8,26]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,4]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[13,23]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[19,23]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[28]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,8]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[16,17,24]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[6,14]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[22,29]}],"complexes":["IKK complex"],"partners":["IKBKB","CHUK","RIPK1","ELKS","SQSTM1","TBK1","MARCH2","N4BP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y6K9","full_name":"NF-kappa-B essential modulator","aliases":["FIP-3","IkB kinase-associated protein 1","IKKAP1","Inhibitor of nuclear factor kappa-B kinase subunit gamma","I-kappa-B kinase subunit gamma","IKK-gamma","IKKG","IkB kinase subunit gamma","NF-kappa-B essential modifier"],"length_aa":419,"mass_kda":48.2,"function":"Regulatory subunit of the IKK core complex which phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor (PubMed:14695475, PubMed:20724660, PubMed:21518757, PubMed:9751060). Its binding to scaffolding polyubiquitin plays a key role in IKK activation by multiple signaling receptor pathways (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308, PubMed:33567255). Can recognize and bind both 'Lys-63'-linked and linear polyubiquitin upon cell stimulation, with a much higher affinity for linear polyubiquitin (PubMed:16547522, PubMed:18287044, PubMed:19033441, PubMed:19185524, PubMed:21606507, PubMed:27777308). Could be implicated in NF-kappa-B-mediated protection from cytokine toxicity. Essential for viral activation of IRF3 (PubMed:19854139). Involved in TLR3- and IFIH1-mediated antiviral innate response; this function requires 'Lys-27'-linked polyubiquitination (PubMed:20724660) (Microbial infection) Also considered to be a mediator for HTLV-1 Tax oncoprotein activation of NF-kappa-B","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9Y6K9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/IKBKG","classification":"Not Classified","n_dependent_lines":109,"n_total_lines":1208,"dependency_fraction":0.0902317880794702},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CHUK","stoichiometry":10.0},{"gene":"IKBKB","stoichiometry":10.0},{"gene":"NFKB1","stoichiometry":4.0},{"gene":"FKBP5","stoichiometry":0.2},{"gene":"RELA","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/IKBKG","total_profiled":1310},"omim":[{"mim_id":"620030","title":"ARGININE- AND SERINE-RICH PROTEIN 1; RSRP1","url":"https://www.omim.org/entry/620030"},{"mim_id":"620004","title":"NMRA-LIKE REDOX SENSOR 1; NMRAL1","url":"https://www.omim.org/entry/620004"},{"mim_id":"619368","title":"LEUCINE-RICH REPEAT-CONTAINING PROTEIN 14; LRRC14","url":"https://www.omim.org/entry/619368"},{"mim_id":"616976","title":"TRIPARTITE MOTIF-CONTAINING PROTEIN 40; TRIM40","url":"https://www.omim.org/entry/616976"},{"mim_id":"616869","title":"C-TERMINAL DOMAIN NUCLEAR ENVELOPE PHOSPHATASE 1 REGULATORY SUBUNIT 1; CNEP1R1","url":"https://www.omim.org/entry/616869"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Cytosol","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/IKBKG"},"hgnc":{"alias_symbol":["IKK-gamma","NEMO","Fip3p","FIP-3","FIP3","IKKAP1","IKKG"],"prev_symbol":["IP2","IP1"]},"alphafold":{"accession":"Q9Y6K9","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y6K9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y6K9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y6K9-F1-predicted_aligned_error_v6.png","plddt_mean":82.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=IKBKG","jax_strain_url":"https://www.jax.org/strain/search?query=IKBKG"},"sequence":{"accession":"Q9Y6K9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y6K9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y6K9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y6K9"}},"corpus_meta":[{"pmid":"9751060","id":"PMC_9751060","title":"IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.","date":"1998","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/9751060","citation_count":794,"is_preprint":false},{"pmid":"10911992","id":"PMC_10911992","title":"NEMO/IKK gamma-deficient mice model incontinentia pigmenti.","date":"2000","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/10911992","citation_count":367,"is_preprint":false},{"pmid":"24446482","id":"PMC_24446482","title":"TNF and IL-1 exhibit distinct ubiquitin requirements for inducing NEMO-IKK supramolecular structures.","date":"2014","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24446482","citation_count":356,"is_preprint":false},{"pmid":"21734245","id":"PMC_21734245","title":"Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.","date":"2011","source":"Clinical microbiology reviews","url":"https://pubmed.ncbi.nlm.nih.gov/21734245","citation_count":294,"is_preprint":false},{"pmid":"15601896","id":"PMC_15601896","title":"The FIP3-Rab11 protein complex regulates recycling endosome targeting to the cleavage furrow during late cytokinesis.","date":"2004","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15601896","citation_count":259,"is_preprint":false},{"pmid":"21458669","id":"PMC_21458669","title":"NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21458669","citation_count":233,"is_preprint":false},{"pmid":"22435563","id":"PMC_22435563","title":"DNA damage-dependent NF-κB activation: NEMO turns nuclear signaling inside out.","date":"2012","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/22435563","citation_count":215,"is_preprint":false},{"pmid":"21187855","id":"PMC_21187855","title":"Nuclear initiated NF-κB signaling: NEMO and ATM take center stage.","date":"2010","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/21187855","citation_count":199,"is_preprint":false},{"pmid":"28939760","id":"PMC_28939760","title":"NEMO-IKKβ Are Essential for IRF3 and NF-κB Activation in the cGAS-STING Pathway.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28939760","citation_count":199,"is_preprint":false},{"pmid":"12890756","id":"PMC_12890756","title":"KSHV vFLIP binds to IKK-gamma to activate IKK.","date":"2003","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/12890756","citation_count":196,"is_preprint":false},{"pmid":"29125880","id":"PMC_29125880","title":"MAVS activates TBK1 and IKKε through TRAFs in NEMO dependent and independent manner.","date":"2017","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/29125880","citation_count":181,"is_preprint":false},{"pmid":"20932476","id":"PMC_20932476","title":"ATM- and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress.","date":"2010","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/20932476","citation_count":171,"is_preprint":false},{"pmid":"20026645","id":"PMC_20026645","title":"Rab11-FIP3 links the Rab11 GTPase and cytoplasmic dynein to mediate transport to the endosomal-recycling compartment.","date":"2009","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/20026645","citation_count":160,"is_preprint":false},{"pmid":"9927690","id":"PMC_9927690","title":"Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9927690","citation_count":147,"is_preprint":false},{"pmid":"20368414","id":"PMC_20368414","title":"IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20368414","citation_count":107,"is_preprint":false},{"pmid":"23989959","id":"PMC_23989959","title":"Molecular control of the NEMO family of ubiquitin-binding proteins.","date":"2013","source":"Nature reviews. Molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23989959","citation_count":105,"is_preprint":false},{"pmid":"14960582","id":"PMC_14960582","title":"Wnt activates the Tak1/Nemo-like kinase pathway.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14960582","citation_count":99,"is_preprint":false},{"pmid":"26555174","id":"PMC_26555174","title":"NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.","date":"2015","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/26555174","citation_count":98,"is_preprint":false},{"pmid":"35477005","id":"PMC_35477005","title":"Liquid phase separation of NEMO induced by polyubiquitin chains activates NF-κB.","date":"2022","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/35477005","citation_count":94,"is_preprint":false},{"pmid":"19373245","id":"PMC_19373245","title":"NEMO/IKKgamma regulates an early NF-kappaB-independent cell-death checkpoint during TNF signaling.","date":"2009","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19373245","citation_count":92,"is_preprint":false},{"pmid":"27929056","id":"PMC_27929056","title":"GSK-3β controls NF-kappaB activity via IKKγ/NEMO.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27929056","citation_count":91,"is_preprint":false},{"pmid":"16987664","id":"PMC_16987664","title":"Posttranslational modifications of NEMO and its partners in NF-kappaB signaling.","date":"2006","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16987664","citation_count":88,"is_preprint":false},{"pmid":"15158446","id":"PMC_15158446","title":"Rab11-FIP3 localises to a Rab11-positive pericentrosomal compartment during interphase and to the cleavage furrow during cytokinesis.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15158446","citation_count":87,"is_preprint":false},{"pmid":"26269396","id":"PMC_26269396","title":"EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.","date":"2015","source":"International reviews of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26269396","citation_count":84,"is_preprint":false},{"pmid":"18350553","id":"PMC_18350553","title":"Alterations of the IKBKG locus and diseases: an update and a report of 13 novel mutations.","date":"2008","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/18350553","citation_count":84,"is_preprint":false},{"pmid":"28679735","id":"PMC_28679735","title":"Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations.","date":"2017","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/28679735","citation_count":82,"is_preprint":false},{"pmid":"17030804","id":"PMC_17030804","title":"Structural basis for Rab11-dependent membrane recruitment of a family of Rab11-interacting protein 3 (FIP3)/Arfophilin-1.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17030804","citation_count":81,"is_preprint":false},{"pmid":"10734145","id":"PMC_10734145","title":"Regulation of the NF-kappaB activation pathway by isolated domains of FIP3/IKKgamma, a component of the IkappaB-alpha kinase complex.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10734145","citation_count":79,"is_preprint":false},{"pmid":"19635861","id":"PMC_19635861","title":"Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage.","date":"2009","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19635861","citation_count":76,"is_preprint":false},{"pmid":"18511905","id":"PMC_18511905","title":"Sequential Cyk-4 binding to ECT2 and FIP3 regulates cleavage furrow ingression and abscission during cytokinesis.","date":"2008","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/18511905","citation_count":75,"is_preprint":false},{"pmid":"37683611","id":"PMC_37683611","title":"Damaged mitochondria recruit the effector NEMO to activate NF-κB signaling.","date":"2023","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/37683611","citation_count":71,"is_preprint":false},{"pmid":"17570222","id":"PMC_17570222","title":"Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury.","date":"2007","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/17570222","citation_count":71,"is_preprint":false},{"pmid":"26347470","id":"PMC_26347470","title":"Brain endothelial TAK1 and NEMO safeguard the neurovascular unit.","date":"2015","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26347470","citation_count":70,"is_preprint":false},{"pmid":"24339369","id":"PMC_24339369","title":"Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease.","date":"2013","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/24339369","citation_count":66,"is_preprint":false},{"pmid":"18685082","id":"PMC_18685082","title":"Arf GTPase-activating protein ASAP1 interacts with Rab11 effector FIP3 and regulates pericentrosomal localization of transferrin receptor-positive recycling endosome.","date":"2008","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18685082","citation_count":65,"is_preprint":false},{"pmid":"23000342","id":"PMC_23000342","title":"Nemo-like kinase, a multifaceted cell signaling regulator.","date":"2012","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/23000342","citation_count":64,"is_preprint":false},{"pmid":"29128367","id":"PMC_29128367","title":"NEMO Links Nuclear Factor-κB to Human Diseases.","date":"2017","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29128367","citation_count":64,"is_preprint":false},{"pmid":"19514049","id":"PMC_19514049","title":"Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells.","date":"2009","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/19514049","citation_count":63,"is_preprint":false},{"pmid":"17394487","id":"PMC_17394487","title":"Rab11-FIP3 is critical for the structural integrity of the endosomal recycling compartment.","date":"2007","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/17394487","citation_count":61,"is_preprint":false},{"pmid":"16647846","id":"PMC_16647846","title":"NEMO, NFkappaB signaling and incontinentia pigmenti.","date":"2006","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/16647846","citation_count":61,"is_preprint":false},{"pmid":"20214888","id":"PMC_20214888","title":"Rab11-FIP3 binds dynein light intermediate chain 2 and its overexpression fragments the Golgi complex.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20214888","citation_count":56,"is_preprint":false},{"pmid":"31844296","id":"PMC_31844296","title":"Herpesviruses induce aggregation and selective autophagy of host signalling proteins NEMO and RIPK1 as an immune-evasion mechanism.","date":"2019","source":"Nature microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31844296","citation_count":56,"is_preprint":false},{"pmid":"11971901","id":"PMC_11971901","title":"Regulation of Ikappa B kinase (IKK)gamma /NEMO function by IKKbeta -mediated phosphorylation.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11971901","citation_count":52,"is_preprint":false},{"pmid":"12901858","id":"PMC_12901858","title":"Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12901858","citation_count":51,"is_preprint":false},{"pmid":"25673879","id":"PMC_25673879","title":"The Arf and Rab11 effector FIP3 acts synergistically with ASAP1 to direct Rabin8 in ciliary receptor targeting.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25673879","citation_count":49,"is_preprint":false},{"pmid":"24270048","id":"PMC_24270048","title":"TRAF6-mediated ubiquitination of NEMO requires p62/sequestosome-1.","date":"2013","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24270048","citation_count":49,"is_preprint":false},{"pmid":"27154205","id":"PMC_27154205","title":"Rac1-Rab11-FIP3 regulatory hub coordinates vesicle traffic with actin remodeling and T-cell activation.","date":"2016","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/27154205","citation_count":47,"is_preprint":false},{"pmid":"30176143","id":"PMC_30176143","title":"Cell-Permeable Bicyclic Peptidyl Inhibitors against NEMO-IκB Kinase Interaction Directly from a Combinatorial Library.","date":"2018","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/30176143","citation_count":47,"is_preprint":false},{"pmid":"19422324","id":"PMC_19422324","title":"NEMO oligomerization and its ubiquitin-binding properties.","date":"2009","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19422324","citation_count":47,"is_preprint":false},{"pmid":"20061393","id":"PMC_20061393","title":"Regulation of FOXO1 by TAK1-Nemo-like kinase pathway.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20061393","citation_count":46,"is_preprint":false},{"pmid":"17628206","id":"PMC_17628206","title":"Molecular characterization of Rab11-FIP3 binding to ARF GTPases.","date":"2007","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17628206","citation_count":44,"is_preprint":false},{"pmid":"30422821","id":"PMC_30422821","title":"Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency.","date":"2018","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/30422821","citation_count":44,"is_preprint":false},{"pmid":"21115542","id":"PMC_21115542","title":"Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis.","date":"2010","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/21115542","citation_count":43,"is_preprint":false},{"pmid":"30917315","id":"PMC_30917315","title":"Nemo-like Kinase Drives Foxp3 Stability and Is Critical for Maintenance of Immune Tolerance by Regulatory T Cells.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30917315","citation_count":42,"is_preprint":false},{"pmid":"19327867","id":"PMC_19327867","title":"Rab11-FIP3 is a Rab11-binding protein that regulates breast cancer cell motility by modulating the actin cytoskeleton.","date":"2009","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19327867","citation_count":41,"is_preprint":false},{"pmid":"33654074","id":"PMC_33654074","title":"N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33654074","citation_count":41,"is_preprint":false},{"pmid":"24926618","id":"PMC_24926618","title":"Nemo-like kinase is critical for p53 stabilization and function in response to DNA damage.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/24926618","citation_count":39,"is_preprint":false},{"pmid":"23904219","id":"PMC_23904219","title":"Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.","date":"2014","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23904219","citation_count":39,"is_preprint":false},{"pmid":"29889904","id":"PMC_29889904","title":"Development of novel NEMO-binding domain mimetics for inhibiting IKK/NF-κB activation.","date":"2018","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/29889904","citation_count":39,"is_preprint":false},{"pmid":"35289316","id":"PMC_35289316","title":"Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/35289316","citation_count":37,"is_preprint":false},{"pmid":"27622210","id":"PMC_27622210","title":"ADP Ribosylation Factor 6 Regulates Neuronal Migration in the Developing Cerebral Cortex through FIP3/Arfophilin-1-dependent Endosomal Trafficking of N-cadherin.","date":"2016","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/27622210","citation_count":36,"is_preprint":false},{"pmid":"30254148","id":"PMC_30254148","title":"An ATM/TRIM37/NEMO Axis Counteracts Genotoxicity by Activating Nuclear-to-Cytoplasmic NF-κB Signaling.","date":"2018","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30254148","citation_count":36,"is_preprint":false},{"pmid":"32286300","id":"PMC_32286300","title":"Modulation of virus-induced NF-κB signaling by NEMO coiled coil mimics.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32286300","citation_count":34,"is_preprint":false},{"pmid":"21790911","id":"PMC_21790911","title":"Distinct roles of Rab11 and Arf6 in the regulation of Rab11-FIP3/arfophilin-1 localization in mitotic cells.","date":"2011","source":"Genes to cells : devoted to molecular & cellular mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/21790911","citation_count":33,"is_preprint":false},{"pmid":"32935379","id":"PMC_32935379","title":"Negative regulation of NEMO signaling by the ubiquitin E3 ligase MARCH2.","date":"2020","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/32935379","citation_count":33,"is_preprint":false},{"pmid":"33951476","id":"PMC_33951476","title":"A kinome screen reveals that Nemo-like kinase is a key suppressor of hepatic gluconeogenesis.","date":"2021","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33951476","citation_count":33,"is_preprint":false},{"pmid":"36720498","id":"PMC_36720498","title":"Linear ubiquitination induces NEMO phase separation to activate NF-κB signaling.","date":"2023","source":"Life science alliance","url":"https://pubmed.ncbi.nlm.nih.gov/36720498","citation_count":32,"is_preprint":false},{"pmid":"19840224","id":"PMC_19840224","title":"Nemo-like kinase is involved in NGF-induced neurite outgrowth via phosphorylating MAP1B and paxillin.","date":"2009","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19840224","citation_count":32,"is_preprint":false},{"pmid":"21177110","id":"PMC_21177110","title":"Clinical and biological significance of nemo-like kinase expression in glioma.","date":"2010","source":"Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia","url":"https://pubmed.ncbi.nlm.nih.gov/21177110","citation_count":31,"is_preprint":false},{"pmid":"21552260","id":"PMC_21552260","title":"Nemo kinase phosphorylates β-catenin to promote ommatidial rotation and connects core PCP factors to E-cadherin-β-catenin.","date":"2011","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21552260","citation_count":31,"is_preprint":false},{"pmid":"38114471","id":"PMC_38114471","title":"NEMO reshapes the α-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38114471","citation_count":30,"is_preprint":false},{"pmid":"20301198","id":"PMC_20301198","title":"Protein-protein interactions involving IKKgamma (NEMO) that promote the activation of NF-kappaB.","date":"2010","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20301198","citation_count":30,"is_preprint":false},{"pmid":"20345847","id":"PMC_20345847","title":"The zinc finger domain of IKKγ (NEMO) protein in health and disease.","date":"2010","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20345847","citation_count":29,"is_preprint":false},{"pmid":"29111346","id":"PMC_29111346","title":"Evidence for M1-Linked Polyubiquitin-Mediated Conformational Change in NEMO.","date":"2017","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29111346","citation_count":28,"is_preprint":false},{"pmid":"21118996","id":"PMC_21118996","title":"Homodimerization of Nemo-like kinase is essential for activation and nuclear localization.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21118996","citation_count":27,"is_preprint":false},{"pmid":"32413485","id":"PMC_32413485","title":"NF-κB inhibitor, NEMO-binding domain peptide attenuates intervertebral disc degeneration.","date":"2020","source":"The spine journal : official journal of the North American Spine Society","url":"https://pubmed.ncbi.nlm.nih.gov/32413485","citation_count":25,"is_preprint":false},{"pmid":"28235866","id":"PMC_28235866","title":"Rab11-FIP3 Regulation of Lck Endosomal Traffic Controls TCR Signal Transduction.","date":"2017","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/28235866","citation_count":24,"is_preprint":false},{"pmid":"31932854","id":"PMC_31932854","title":"DNA-PK: gatekeeper for IKKγ/NEMO nucleocytoplasmic shuttling in genotoxic stress-induced NF-kappaB activation.","date":"2020","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/31932854","citation_count":24,"is_preprint":false},{"pmid":"18201555","id":"PMC_18201555","title":"NEMO shuttle: a link between DNA damage and NF-kappaB activation in progeroid syndromes?","date":"2008","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18201555","citation_count":23,"is_preprint":false},{"pmid":"26363086","id":"PMC_26363086","title":"Nemo like kinase negatively regulates NF-κB activation and coelomocytes apoptosis in Apostichopus japonicus.","date":"2015","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26363086","citation_count":23,"is_preprint":false},{"pmid":"20133626","id":"PMC_20133626","title":"A mutation of Ikbkg causes immune deficiency without impairing degradation of IkappaB alpha.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20133626","citation_count":23,"is_preprint":false},{"pmid":"27464707","id":"PMC_27464707","title":"Epithelial NEMO/IKKγ limits fibrosis and promotes regeneration during pancreatitis.","date":"2016","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/27464707","citation_count":23,"is_preprint":false},{"pmid":"34301812","id":"PMC_34301812","title":"ATM/NEMO signaling modulates the expression of PD-L1 following docetaxel chemotherapy in prostate cancer.","date":"2021","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/34301812","citation_count":23,"is_preprint":false},{"pmid":"30814588","id":"PMC_30814588","title":"The IKK-binding domain of NEMO is an irregular coiled coil with a dynamic binding interface.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30814588","citation_count":22,"is_preprint":false},{"pmid":"29803790","id":"PMC_29803790","title":"Nemo-like kinase (NLK) primes colorectal cancer progression by releasing the E2F1 complex from HDAC1.","date":"2018","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/29803790","citation_count":22,"is_preprint":false},{"pmid":"38505605","id":"PMC_38505605","title":"Dual regulation of NEMO by Nrf2 and miR-125a inhibits ferroptosis and protects liver from endoplasmic reticulum stress-induced injury.","date":"2024","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/38505605","citation_count":21,"is_preprint":false},{"pmid":"24395089","id":"PMC_24395089","title":"Expression of Nemo-like kinase after spinal cord injury in rats.","date":"2014","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/24395089","citation_count":20,"is_preprint":false},{"pmid":"36181338","id":"PMC_36181338","title":"TREM-1 induces pyroptosis in cardiomyocytes by activating NLRP3 inflammasome through the SMC4/NEMO pathway.","date":"2022","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/36181338","citation_count":20,"is_preprint":false},{"pmid":"30943066","id":"PMC_30943066","title":"Peptidyl arginine deiminase-4 exacerbates ischemic AKI by finding NEMO.","date":"2019","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30943066","citation_count":20,"is_preprint":false},{"pmid":"18266324","id":"PMC_18266324","title":"High-affinity interaction between IKKbeta and NEMO.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18266324","citation_count":20,"is_preprint":false},{"pmid":"20457134","id":"PMC_20457134","title":"Proteins that bind to IKKgamma (NEMO) and down-regulate the activation of NF-kappaB.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20457134","citation_count":20,"is_preprint":false},{"pmid":"26427665","id":"PMC_26427665","title":"The emerging role of Nemo-like kinase (NLK) in the regulation of cancers.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26427665","citation_count":19,"is_preprint":false},{"pmid":"20116374","id":"PMC_20116374","title":"Nemo-like kinase (NLK) expression in osteoblastic cells and suppression of osteoblastic differentiation.","date":"2010","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/20116374","citation_count":18,"is_preprint":false},{"pmid":"16473615","id":"PMC_16473615","title":"Purification and functional properties of Rab11-FIP3.","date":"2005","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/16473615","citation_count":18,"is_preprint":false},{"pmid":"31549402","id":"PMC_31549402","title":"SENP1-mediated NEMO de-SUMOylation inhibits intermittent hypoxia induced inflammatory response of microglia in vitro.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/31549402","citation_count":18,"is_preprint":false},{"pmid":"26308581","id":"PMC_26308581","title":"Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26308581","citation_count":17,"is_preprint":false},{"pmid":"33676893","id":"PMC_33676893","title":"The phosphorylation of the Smad2/3 linker region by nemo-like kinase regulates TGF-β signaling.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33676893","citation_count":17,"is_preprint":false},{"pmid":"33276680","id":"PMC_33276680","title":"Nemo-Like Kinase in Development and Diseases: Insights from Mouse Studies.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33276680","citation_count":16,"is_preprint":false},{"pmid":"24324710","id":"PMC_24324710","title":"A nonsense mutation in the IKBKG gene in mares with incontinentia pigmenti.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24324710","citation_count":16,"is_preprint":false},{"pmid":"23131831","id":"PMC_23131831","title":"Novel Phosphorylations of IKKγ/NEMO.","date":"2012","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/23131831","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47119,"output_tokens":8555,"usd":0.134841,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18508,"output_tokens":6779,"usd":0.131007,"stage2_stop_reason":"end_turn"},"total_usd":0.265848,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"IKK-gamma (NEMO) is an essential regulatory subunit of the IκB kinase complex, composed of similar amounts of IKK-alpha, IKK-beta, and two differentially processed forms of IKK-gamma. IKK-gamma interacts preferentially with IKK-beta and is required for activation of the IKK complex; a C-terminal truncation mutant that still binds IKK-beta acts as a dominant negative, blocking IKK and NF-κB activation.\",\n      \"method\": \"Purification to homogeneity by monoclonal antibody affinity, molecular cloning, dominant-negative truncation mutant assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — IKK complex purified to homogeneity, subunit identity confirmed by sequencing, functional requirement established by dominant-negative mutant; foundational paper widely replicated\",\n      \"pmids\": [\"9751060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"NEMO/IKKgamma is essential for NF-κB activation by proinflammatory cytokines in vivo; complete NEMO disruption causes male embryonic lethality due to massive hepatocyte apoptosis and completely blocks NF-κB activation, phenocopying incontinentia pigmenti in heterozygous females.\",\n      \"method\": \"Germline and conditional knockout mouse models, NF-κB activation assays, histology\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with defined molecular (NF-κB) and cellular (apoptosis, embryonic lethality) phenotypes, replicated in subsequent studies\",\n      \"pmids\": [\"10911992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"FIP-3/NEMO (identified as a 14.7K adenovirus-interacting protein) inhibits NF-κB by stabilizing IκB-α (blocking TNF-α-induced IκB-α phosphorylation and degradation) and binds RIP and NIK. Its N-terminal 119 amino acids mediate IKK-beta and IKK-alpha interactions; residues 201-300 mediate self-association and RIP interaction; and the C-terminal half mediates NF-κB inhibitory activity.\",\n      \"method\": \"Co-immunoprecipitation, deletion mutagenesis, IκB-α phosphorylation assay, NF-κB reporter assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain mapping by deletion mutants with multiple functional readouts in a single lab\",\n      \"pmids\": [\"9927690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The N-terminal 119 amino acids of FIP3/NEMO mediate interaction with IKK-beta and IKK-alpha; the carboxy-terminal half contains the NF-κB inhibitory domain and blocks IκB-α phosphorylation/degradation; residues 201-300 constitute the self-association domain and FIP3-RIP interaction domain.\",\n      \"method\": \"Deletion mutant expression, co-immunoprecipitation, IκB-α phosphorylation assay, NF-κB reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic domain mapping with multiple orthogonal functional readouts, single lab\",\n      \"pmids\": [\"10734145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"IKK-beta phosphorylates IKK-gamma/NEMO predominantly at serine 369 in the C-terminus (as well as sites in the central region) both in vitro and in vivo upon TNF-α and IL-1 stimulation; mutation of these C-terminal serines increases IKKgamma's ability to stimulate IKKbeta kinase activity, indicating feedback regulation.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, in vivo phosphorylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay combined with mutagenesis and in vivo validation, single lab but two orthogonal methods\",\n      \"pmids\": [\"11971901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"KSHV vFLIP binds IKK-gamma/NEMO at the central CCR3/4 region (amino acids 150-272) to activate the IKK complex; in KSHV-infected PEL cells, vFLIP co-elutes with an activated IKK complex (IKKalpha, IKKbeta, IKKgamma) and associates with the chaperone Hsp90, whose inhibition by geldanamycin blocks vFLIP-induced IKK activation.\",\n      \"method\": \"Yeast two-hybrid screen, bacterial/mammalian fragment expression, co-immunoprecipitation, mass spectrometry, gel filtration chromatography, Hsp90 inhibitor assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, mass spectrometry, domain mapping, and functional inhibitor studies across multiple orthogonal methods\",\n      \"pmids\": [\"12890756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NEMO/IKKgamma has an NF-κB-independent antiapoptotic function: it prevents RIP1 from engaging caspase-8 at an early checkpoint prior to NF-κB-mediated transcription. In NEMO-deficient cells, RIP1 associates with caspase-8, causing rapid TNF-induced apoptosis independent of NF-κB status.\",\n      \"method\": \"NEMO-deficient cell lines, co-immunoprecipitation of RIP1-caspase-8 complex, NF-κB-independent rescue experiments\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with defined molecular interaction (RIP1-caspase-8 co-IP) and NF-κB independence demonstrated, single lab\",\n      \"pmids\": [\"19373245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NEMO exists as a highly elongated dimer in solution that is in weak equilibrium with a tetrameric assembly. IKKbeta peptide binding disrupts tetramerization (mutually exclusive with IKK binding). NEMO binds linear di-ubiquitin with 1:1 stoichiometry per dimer (one di-ubiquitin per NEMO dimer), with a second weaker binding site apparent at higher concentrations.\",\n      \"method\": \"Hydrodynamic/biophysical analysis (sedimentation, gel filtration), isothermal titration calorimetry, stoichiometry determination\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — rigorous biophysical reconstitution with multiple hydrodynamic methods and quantitative binding measurements, single lab\",\n      \"pmids\": [\"19422324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In the genotoxic stress pathway, ATM activates the IKK kinase TAK1 through NEMO/IKKgamma and ELKS (a protein rich in Glu/Leu/Lys/Ser). K63-linked polyubiquitination of ELKS (by XIAP/UBC13) enables ELKS association with TAK1 via TAB2/3; NEMO associates with ELKS through its ubiquitin-binding domain, assembling TAK1/TAB2/3 and NEMO/IKK complexes to activate NF-κB.\",\n      \"method\": \"Cell-based co-IP, ubiquitin-binding domain mutants, ELKS knockdown, reconstitution of complex assembly\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis and co-IP in multiple cell systems with defined ubiquitin-binding mutants, pathway ordering demonstrated\",\n      \"pmids\": [\"20932476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BAG3 promotes survival by altering the interaction between Hsp70 and IKKgamma, increasing IKKgamma availability and protecting it from proteasome-dependent degradation, thereby increasing NF-κB activity.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, xenograft tumor model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP showing BAG3-Hsp70-IKKgamma interaction with functional readout (NF-κB activity, proteasomal degradation), single lab\",\n      \"pmids\": [\"20368414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In response to extensive DNA damage, ATM drives two sequential NF-κB activation phases both requiring NEMO/IKKgamma: the first induces TNF-α-TNFR1 feedforward signaling, promoting the second phase and driving RIP1 phosphorylation; RIP1 kinase then triggers JNK3-dependent IL-8 secretion and FADD-mediated caspase-8 activation, switching on cytokine production and apoptosis.\",\n      \"method\": \"Genetic knockdown/knockout of NEMO, ATM inhibition, sequential NF-κB activation assays, RIP1 phosphorylation analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with multiple pathway components, well-controlled sequential activation assays, published in high-impact journal with extensive mechanistic detail\",\n      \"pmids\": [\"21458669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Src family protein tyrosine kinases (Src, Fyn, Lyn, Fgr) interact with and phosphorylate IKKgamma/NEMO at tyrosine 374 (Y374); Y374F mutation abrogates this phosphorylation and increases TNF-α-induced NF-κB activity. Additionally, KSHV vFLIP expression induces phosphorylation of serine 377 (S377); S377A mutation increases and S377E decreases NF-κB activity and IL-6 production, indicating negative feedback regulation.\",\n      \"method\": \"In vitro kinase assay, site-directed mutagenesis, mass spectrometry, NF-κB reporter assay, cytokine ELISA\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay, MS identification of sites, mutagenesis with functional NF-κB readout, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"23131831\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TRAF6-mediated ubiquitination of NEMO requires the scaffold protein p62/sequestosome-1. p62 interacts with NEMO; siRNA depletion of p62 abrogates TRAF6-induced NEMO ubiquitination and severely impairs NF-κB activation following IL-1β stimulation.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, ubiquitination assay, NF-κB activation assay\",\n      \"journal\": \"Molecular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP plus functional siRNA knockdown with defined ubiquitination readout, single lab\",\n      \"pmids\": [\"24270048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TNF and IL-1 stimulation induces rapid, transient recruitment of NEMO into punctate supramolecular structures at the cell periphery that are enriched in activated IKK and ubiquitinated NEMO, and colocalize with activated TNF receptors but not IL-1 receptors. IL-1 (but not TNF) requires K63-linked and LUBAC-generated linear ubiquitin chains to recruit NEMO into these structures.\",\n      \"method\": \"Live-cell fluorescence microscopy, super-resolution imaging, cells deficient in K63 ubiquitin or LUBAC components\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — live imaging with genetic cell systems deficient in specific ubiquitin linkages, multiple orthogonal approaches\",\n      \"pmids\": [\"24446482\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NEMO prevents hepatocarcinogenesis by inhibiting RIPK1 kinase activity-driven hepatocyte apoptosis through both NF-κB-dependent and NF-κB-independent functions. Combined RelA/c-Rel/RelB deletion did not phenocopy NEMO deficiency; knock-in of kinase-inactive RIPK1 prevented hepatocyte apoptosis and HCC; RIPK1 ablation induced TRADD-dependent apoptosis, revealing distinct kinase-dependent and scaffolding functions of RIPK1 downstream of NEMO.\",\n      \"method\": \"Conditional liver-specific KO mice, RIPK1 kinase-dead knock-in, genetic epistasis with triple NF-κB subunit deletion\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models with epistasis, conditional KO, and knock-in, rigorous dissection of NF-κB-dependent vs independent NEMO functions\",\n      \"pmids\": [\"26555174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GSK-3β directly phosphorylates NEMO at serines 8, 17, 31, and 43 within its N-terminal domain and forms a complex with wild-type NEMO; point mutations at these serines abolish GSK-3β binding and phosphorylation, leading to NEMO destabilization but augmented K63-linked polyubiquitination and increased binding to IKKα and IKKβ, while impairing ordered TNF-α-induced NF-κB signaling.\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, site-directed mutagenesis, ubiquitination assay\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay with mutagenesis, single lab\",\n      \"pmids\": [\"27929056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In the cGAS-STING pathway, cytosolic DNA activates TRIM32 and TRIM56 to synthesize ubiquitin chains that bind NEMO, which subsequently activates IKKβ (not IKKα). Activated IKKβ is required for TBK1 and NF-κB activation, and TBK1 reciprocally activates IKKβ, forming a positive feedback loop for robust cytokine production.\",\n      \"method\": \"Genetic knockouts (NEMO, IKKβ, TBK1), ubiquitin chain synthesis assays, NF-κB and IFN reporter assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic cell systems with multiple pathway components tested, single lab\",\n      \"pmids\": [\"28939760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MAVS-mediated innate immune activation is partially dependent on NEMO: TRAFs' E3 ligase activity synthesizes ubiquitin chains that bind NEMO for NF-κB activation; NEMO-activated IKKα/β then phosphorylate TBK1/IKKε, linking the NEMO-dependent ubiquitin scaffold to TBK1/IKKε activation.\",\n      \"method\": \"TRAF quadruple KO cells, NEMO-deficient cells, ubiquitin chain binding assay, phosphorylation analysis\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO epistasis with pathway ordering, single lab\",\n      \"pmids\": [\"29125880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Evidence for M1-linked polyubiquitin-mediated conformational change in NEMO: NEMO adopts a compact conformation (Dmax ~320 Å) rather than fully extended. A region (residues 112-150) in coiled-coil 1 inhibits di-ubiquitin binding to the CC2-LZ domain, and this auto-inhibition is overcome only by longer M1-linked (not K63-linked) polyubiquitin chains, suggesting allosteric activation.\",\n      \"method\": \"SEC-SAXS (size exclusion chromatography-small angle X-ray scattering), in vitro ubiquitin-binding assays with truncation mutants\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — structural method (SAXS) plus in vitro binding assays, single lab, conformational model supported but not fully validated by mutagenesis\",\n      \"pmids\": [\"29111346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"TRIM37 monoubiquitinates NEMO at K309 in the nucleus in response to genotoxic stress (ATM-phosphorylated TRIM37 translocates to the nucleus); this monoubiquitination triggers nuclear export of NEMO and subsequent IKK/NF-κB activation. The ATM/TRIM37/NEMO nuclear-to-cytoplasmic axis mediates genotoxic NF-κB activation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay with K309 mutant, nuclear fractionation, cell-penetrating inhibitor peptide, in vivo xenograft\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP, site-specific ubiquitination assay, nuclear fractionation with functional readout, single lab\",\n      \"pmids\": [\"30254148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The IKKβ-binding domain of NEMO forms an irregular coiled coil with a dynamic interface: the unbound structure adopts a closed conformation that partially occludes three binding hot-spots and can transition to an open state for ligand binding.\",\n      \"method\": \"X-ray crystallography of unbound NEMO IKKβ-binding domain, fusion protein engineering\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure of NEMO domain with functional inference, single lab\",\n      \"pmids\": [\"30814588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PAD4 preferentially citrullinates IKKgamma/NEMO (over IKKα or IKKβ), and this citrullination promotes NF-κB activation via IκBα phosphorylation in renal proximal tubular cells. NEMO citrullination by PAD4 contributes to ischemia-reperfusion-induced NF-κB activation and acute kidney injury.\",\n      \"method\": \"In vitro citrullination assay with recombinant proteins, IκBα phosphorylation assay, NEMO-binding peptide inhibition, in vivo ischemia-reperfusion model\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro reconstitution with recombinant proteins, functional cell-based validation, single lab\",\n      \"pmids\": [\"30943066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Murine cytomegalovirus M45 protein induces aggregation and selective autophagy of NEMO (and RIPK1) as an immune evasion mechanism. M45 contains an 'induced protein aggregation motif' that triggers NEMO sequestration into insoluble aggregates, followed by recruitment of VPS26B and LC3-interacting adaptor TBC1D5 to degrade aggregates by selective autophagy (aggrephagy).\",\n      \"method\": \"Protein aggregation assays, autophagy flux assays, mutant M45 analysis, co-immunoprecipitation\",\n      \"journal\": \"Nature microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined protein motif with functional consequence, multiple viral orthologs tested, single primary model system\",\n      \"pmids\": [\"31844296\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DNA-PK phosphorylates NEMO at serine 43, enabling its nuclear entry (SUMOylation) and subsequent nucleocytoplasmic shuttling for NF-κB activation in response to genotoxic stress. DNA-PK knockdown or S43A point mutation blocks NEMO nuclear entry and abolishes ionizing radiation-induced NF-κB activation.\",\n      \"method\": \"Site-directed mutagenesis (S43A), shRNA knockdown of DNA-PKcs, nuclear fractionation, SUMOylation assay, NF-κB activation assay\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis plus genetic knockdown with nuclear fractionation, single lab\",\n      \"pmids\": [\"31932854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MARCH2 is a novel E3 ubiquitin ligase that negatively regulates NEMO by directly interacting with NEMO during the late phase of infection and catalyzing K48-linked ubiquitination of Lys326 on NEMO, leading to its proteasomal degradation and dampening innate immune responses.\",\n      \"method\": \"Co-immunoprecipitation, in vitro ubiquitination assay, site-directed mutagenesis (K326), MARCH2 knockout mice\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct interaction demonstrated by co-IP, site-specific ubiquitination mapped by mutagenesis, in vivo KO validation with infectious phenotype\",\n      \"pmids\": [\"32935379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"N4BP1 inhibits TLR-dependent NF-κB activation by directly binding NEMO to attenuate NEMO-NEMO dimerization/oligomerization. The UBA-like and CUE-like domains of N4BP1 interact with the NEMO COZI domain. TRIF-activated caspase-8 cleaves N4BP1 to abolish its inhibitory effect, selectively enabling TLR4/TLR3-mediated NF-κB signaling.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, N4bp1 knockout mice, in vitro binding assay, caspase-8 cleavage assay\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, domain mapping, in vitro binding, KO mice with in vivo phenotype, caspase cleavage mechanism\",\n      \"pmids\": [\"33654074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Polyubiquitin chains (K63-linked or linear/M1-linked) binding to NEMO robustly induce liquid-liquid phase separation of NEMO into droplets in which IKK is activated. Both the NUB domain and zinc-finger domain of NEMO contribute to polyUb binding and phase separation. NEMO mutations associated with human immunodeficiency impair phase separation. NEMO phase separation is required for IKK and NF-κB activation.\",\n      \"method\": \"In vitro reconstitution of phase separation with purified proteins, cell-based phase separation assay, disease-associated mutant analysis, IKK activation assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of phase separation with purified components, cell-based validation, domain mutants, disease mutants tested; multiple orthogonal methods\",\n      \"pmids\": [\"35477005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A NEMO isoform lacking exon 5 (NEMO-Δex5) fails to associate with TBK1, impairing TLR3/RIG-I responses but not TNF-induced NF-κB. In immune cells expressing NEMO-Δex5, the inducible IKK protein (IKKi) is stabilized by NEMO-Δex5, promoting type I IFN induction. This establishes exon 5 as required for TBK1 association and regulation of the IFN response.\",\n      \"method\": \"Patient-derived cells, co-immunoprecipitation of NEMO-Δex5 with TBK1, TLR3/RIG-I vs TNF stimulation assays, IKKi stabilization assay\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — patient cell-based co-IP, isoform functional dissection, single lab\",\n      \"pmids\": [\"35289316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NEMO is recruited to damaged mitochondria in a Parkin-dependent manner, where it partitions into phase-separated condensates colocalizing with p62. Recruitment of NEMO to damaged mitochondria brings active phospho-IKKβ, initiating NF-κB signaling and upregulation of inflammatory cytokines. This occurs in parallel with mitophagy as a damage-sensing platform.\",\n      \"method\": \"Live-cell fluorescence imaging, FRAP, Parkin knockout validation, fractionation, IKKβ phosphorylation assay\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization by live imaging, genetic (Parkin KO) requirement, IKKβ recruitment with functional NF-κB readout, multiple orthogonal methods\",\n      \"pmids\": [\"37683611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NEMO promotes autophagosomal clearance of protein aggregates in an NF-κB-independent manner. NEMO amplifies linear ubiquitylation at α-synuclein aggregates and promotes local concentration of p62 into foci. In vitro, NEMO lowers the threshold concentration required for ubiquitin-dependent phase transition of p62, reshaping the aggregate surface for efficient autophagic clearance.\",\n      \"method\": \"In vitro phase separation reconstitution, patient cell analysis, co-condensation assays with p62 and ubiquitin\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro reconstitution of phase transition plus patient cell validation, single lab, novel NF-κB-independent function\",\n      \"pmids\": [\"38114471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"M1-linked (linear) ubiquitin chains induce phase separation of NEMO and formation of NEMO assemblies in cells after IL-1β stimulation. Phase separation is driven by both non-covalent NEMO binding to linear ubiquitin chains and covalent linkage of M1-ubiquitin to NEMO; a pathogenic NEMO mutant defective in both binding and covalent linkage to linear ubiquitin does not undergo phase separation and is defective in IL-1β-induced NF-κB activation.\",\n      \"method\": \"In vitro phase separation assay, cell-based condensate formation, disease mutant analysis, NF-κB reporter assay\",\n      \"journal\": \"Life science alliance\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — in vitro reconstitution and cell-based validation, disease mutant mechanistic insight, single lab\",\n      \"pmids\": [\"36720498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SENP1-mediated de-SUMOylation of NEMO inhibits NF-κB activation in intermittent hypoxia-challenged microglia. Intermittent hypoxia enhances NEMO SUMOylation; overexpression of SENP1 decreases NEMO SUMOylation and suppresses NF-κB activation and proinflammatory cytokine production.\",\n      \"method\": \"Co-immunoprecipitation for SUMOylation, SENP1 overexpression, NF-κB reporter assay, cytokine ELISA\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP for SUMOylation with functional readout, single lab\",\n      \"pmids\": [\"31549402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"High-affinity interaction between IKKβ and NEMO requires a longer C-terminal region of IKKβ beyond the minimal NBD peptide. The longer IKKβ C-terminal region forms a 2:2 stoichiometric complex with NEMO, as measured by surface plasmon resonance, ITC, and MALS.\",\n      \"method\": \"Surface plasmon resonance, isothermal titration calorimetry, multiangle light scattering\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — quantitative biophysical reconstitution with three orthogonal methods, single lab\",\n      \"pmids\": [\"18266324\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NEMO/IKKgamma (IKBKG) is the essential regulatory/scaffold subunit of the IκB kinase complex that binds preferentially to IKKβ (and IKKα) through its N-terminal region and integrates upstream signals—primarily non-degradative K63-linked and M1-linked polyubiquitin chains—via its NUB and zinc-finger domains to promote IKK activation through liquid-liquid phase separation; NEMO undergoes extensive post-translational regulation (phosphorylation by IKKβ, GSK-3β, DNA-PK, and Src-family kinases; K63-linked ubiquitination by TRAF6/p62; K48-linked ubiquitination for degradation by MARCH2; monoubiquitination at K309 by TRIM37; SUMOylation/de-SUMOylation) that modulates its activity, localization, and stability; it shuttles between cytoplasm and nucleus in response to DNA damage (ATM/DNA-PK-dependent), serves an NF-κB-independent antiapoptotic function by restraining RIP1 from engaging caspase-8, is recruited to damaged ubiquitinated mitochondria in a Parkin-dependent manner to initiate NF-κB signaling, and promotes autophagosomal clearance of protein aggregates independently of NF-κB by co-condensing with p62.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"IKBKG (NEMO/IKKγ) is the essential non-catalytic regulatory subunit of the IκB kinase complex and the central scaffold that couples upstream signals to NF-κB activation [#0, #1]. Through its N-terminal region it binds preferentially to IKKβ (and IKKα), forming a defined high-affinity 2:2 complex, and its loss completely blocks cytokine-induced NF-κB activation, causing embryonic lethality from massive hepatocyte apoptosis and phenocopying incontinentia pigmenti in heterozygous females [#1, #32]. NEMO functions as a ubiquitin sensor: K63-linked and M1/linear polyubiquitin chains, generated by upstream E3 ligases, engage its NUB and zinc-finger domains and drive its assembly into liquid-liquid phase-separated condensates within which IKK is activated, with disease-associated NEMO mutations impairing both ubiquitin engagement and phase separation [#26, #30, #18]. This ubiquitin-scaffold logic operates across diverse inputs—TNF and IL-1 receptor signaling [#13], genotoxic stress via ATM [#10], and cytosolic nucleic-acid sensing through cGAS-STING and MAVS [#16, #17]. NEMO activity is tuned by extensive post-translational modification, including feedback phosphorylation by IKKβ, GSK-3β, DNA-PK and Src-family kinases, K63-linked ubiquitination requiring p62/TRAF6, K48-linked degradative ubiquitination by MARCH2, and SUMOylation [#4, #11, #15, #23, #12, #24, #31]. Beyond transcription, NEMO carries an NF-κB-independent antiapoptotic role, restraining RIPK1 from engaging caspase-8 and thereby preventing hepatocyte death and hepatocarcinogenesis [#6, #14], is recruited to Parkin-marked damaged mitochondria to initiate inflammatory signaling [#28], and co-condenses with p62 to promote autophagic clearance of protein aggregates independently of NF-κB [#29].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established that the IKK complex contains an essential regulatory subunit distinct from its catalytic kinases, defining NEMO as required for IKK/NF-κB activation.\",\n      \"evidence\": \"Antibody affinity purification of the IKK complex to homogeneity, cloning, and dominant-negative truncation mutants\",\n      \"pmids\": [\"9751060\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define how upstream signals engage the subunit\", \"No structural basis for IKKβ binding\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapped NEMO's modular architecture, assigning IKK binding to the N-terminus, self-association/RIP interaction to a central region, and NF-κB regulatory activity to the C-terminus.\",\n      \"evidence\": \"Co-IP and deletion mutagenesis with IκBα phosphorylation and NF-κB reporter readouts\",\n      \"pmids\": [\"9927690\", \"10734145\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Domain boundaries inferred from deletions, not structure\", \"Single-lab functional readouts\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrated in vivo that NEMO is indispensable for cytokine-induced NF-κB, linking its loss to hepatocyte apoptosis and human incontinentia pigmenti.\",\n      \"evidence\": \"Germline and conditional NEMO knockout mice with NF-κB assays and histology\",\n      \"pmids\": [\"10911992\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not separate scaffold from ubiquitin-sensing functions\", \"Mechanism of apoptosis protection unresolved at this stage\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identified NEMO as a substrate of its own complex, revealing IKKβ-mediated C-terminal phosphorylation as a negative feedback control on IKK activity.\",\n      \"evidence\": \"In vitro and in vivo kinase assays with site-directed mutagenesis (S369)\",\n      \"pmids\": [\"11971901\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological kinetics of feedback not quantified\", \"Other modifying kinases not yet identified\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the stoichiometry and affinity determinants of the core IKKβ-NEMO interaction, showing a 2:2 complex requiring more than the minimal NBD peptide.\",\n      \"evidence\": \"SPR, ITC, and MALS biophysical reconstitution\",\n      \"pmids\": [\"18266324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length complex structure\", \"Conformational dynamics of binding not addressed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed NEMO's solution architecture and ubiquitin-binding behavior, showing an elongated dimer that binds linear di-ubiquitin and whose tetramerization is mutually exclusive with IKK binding.\",\n      \"evidence\": \"Hydrodynamic analysis and ITC stoichiometry measurements\",\n      \"pmids\": [\"19422324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of tetramer in cells unclear\", \"Did not address longer/branched ubiquitin chains\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Uncovered an NF-κB-independent survival function in which NEMO blocks RIP1-caspase-8 association at an early checkpoint.\",\n      \"evidence\": \"NEMO-deficient cells with RIP1-caspase-8 co-IP and NF-κB-independent rescue\",\n      \"pmids\": [\"19373245\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of RIP1 restraint not defined\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Connected NEMO to genotoxic-stress NF-κB activation through ubiquitin-dependent assembly of TAK1 and IKK complexes via ELKS.\",\n      \"evidence\": \"Cell-based co-IP, ubiquitin-binding-domain mutants, and ELKS knockdown\",\n      \"pmids\": [\"20932476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vitro reconstitution of the assembly not shown\", \"Quantitative ubiquitin chain requirements unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed NEMO abundance is set by chaperone-dependent stability control, with BAG3 modulating Hsp70-NEMO interaction to protect NEMO from proteasomal degradation.\",\n      \"evidence\": \"Co-IP, siRNA knockdown, and xenograft tumor model\",\n      \"pmids\": [\"20368414\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect chaperone effect not separated\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Placed NEMO at the head of a biphasic ATM-driven NF-κB program that toggles between cytokine production and apoptosis after DNA damage.\",\n      \"evidence\": \"Genetic NEMO/ATM perturbation with sequential NF-κB and RIP1 phosphorylation assays\",\n      \"pmids\": [\"21458669\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of NEMO nuclear involvement not yet defined here\", \"Cell-type generality unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Expanded the phospho-regulatory code, identifying Src-family tyrosine phosphorylation (Y374) and vFLIP-induced S377 phosphorylation as feedback brakes on NF-κB.\",\n      \"evidence\": \"In vitro kinase assays, MS site mapping, mutagenesis, and NF-κB/cytokine readouts\",\n      \"pmids\": [\"23131831\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological stimuli engaging Src kinases on NEMO unclear\", \"Crosstalk with other PTMs not addressed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established that p62/sequestosome-1 is required for TRAF6-mediated K63 ubiquitination of NEMO downstream of IL-1β.\",\n      \"evidence\": \"Co-IP, siRNA knockdown, ubiquitination and NF-κB activation assays\",\n      \"pmids\": [\"24270048\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs scaffolded ubiquitination not distinguished\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Visualized stimulus-specific recruitment of NEMO into ubiquitin-dependent peripheral supramolecular structures, distinguishing TNF from IL-1 ubiquitin requirements.\",\n      \"evidence\": \"Live-cell and super-resolution imaging in K63/LUBAC-deficient cells\",\n      \"pmids\": [\"24446482\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Material state of structures not defined at this stage\", \"Spatial relationship to receptor not fully resolved for IL-1\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Dissected the dual NF-κB-dependent and -independent NEMO functions that suppress RIPK1 kinase-driven hepatocyte apoptosis and hepatocarcinogenesis.\",\n      \"evidence\": \"Liver-specific conditional KO, RIPK1 kinase-dead knock-in, and triple NF-κB subunit deletion epistasis\",\n      \"pmids\": [\"26555174\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of the NF-κB-independent activity not biochemically defined\", \"How NEMO restrains RIPK1 kinase activity unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified GSK-3β as an N-terminal NEMO kinase whose phosphorylation stabilizes NEMO and orders TNF-α-induced NF-κB signaling.\",\n      \"evidence\": \"In vitro kinase assay, co-IP, mutagenesis, and ubiquitination assay\",\n      \"pmids\": [\"27929056\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance not established\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Positioned NEMO as a ubiquitin-sensing hub in cytosolic nucleic-acid immunity, linking cGAS-STING and MAVS to IKKβ and reciprocal TBK1 activation.\",\n      \"evidence\": \"Genetic KO epistasis with ubiquitin chain synthesis/binding and reporter assays\",\n      \"pmids\": [\"28939760\", \"29125880\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of physiological ubiquitin ligases in each pathway not fully resolved\", \"Single-lab findings\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Provided a structural rationale for chain-length-selective activation, showing NEMO is autoinhibited and preferentially activated by longer M1-linked over K63-linked chains.\",\n      \"evidence\": \"SEC-SAXS with truncation-mutant ubiquitin-binding assays\",\n      \"pmids\": [\"29111346\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Conformational model not validated by full mutagenesis\", \"Atomic-resolution structure of activated state lacking\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined a nuclear-to-cytoplasmic NEMO relay in genotoxic signaling via TRIM37 monoubiquitination at K309 driving nuclear export.\",\n      \"evidence\": \"Co-IP, K309 ubiquitination mutant, nuclear fractionation, inhibitor peptide, and xenograft\",\n      \"pmids\": [\"30254148\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Export machinery reading the monoubiquitin mark not identified\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Resolved the IKKβ-binding domain structure, revealing a dynamic closed-to-open conformational switch governing ligand engagement.\",\n      \"evidence\": \"X-ray crystallography of the unbound NEMO IKKβ-binding domain\",\n      \"pmids\": [\"30814588\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Open state not captured structurally\", \"Coupling to full-length activation untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Added citrullination (by PAD4) and SUMOylation control (by SENP1) to the NEMO modification repertoire with disease-relevant functional consequences.\",\n      \"evidence\": \"In vitro citrullination/SUMOylation assays, SENP1 overexpression, and in vivo injury models\",\n      \"pmids\": [\"30943066\", \"31549402\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Modified residues and their structural effects partly undefined\", \"Single-lab findings\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Revealed viral subversion of NEMO via induced aggregation and selective autophagy, establishing aggrephagy of NEMO as an immune-evasion route.\",\n      \"evidence\": \"Protein aggregation and autophagy flux assays with M45 mutants and co-IP\",\n      \"pmids\": [\"31844296\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Host adaptor recruitment hierarchy partly inferred\", \"Generality beyond viral context untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed DNA-PK phosphorylation of NEMO at S43 licenses its nuclear entry and shuttling for genotoxic NF-κB activation.\",\n      \"evidence\": \"S43A mutagenesis, DNA-PKcs knockdown, nuclear fractionation, and SUMOylation/NF-κB assays\",\n      \"pmids\": [\"31932854\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Integration with ATM/TRIM37 axis not reconciled\", \"Single-lab finding\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identified MARCH2 as an E3 ligase that degrades NEMO via K48-linked ubiquitination at K326 to dampen innate immune responses.\",\n      \"evidence\": \"Co-IP, in vitro ubiquitination, K326 mutagenesis, and MARCH2 knockout mice\",\n      \"pmids\": [\"32935379\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Temporal trigger for late-phase MARCH2 engagement unclear\", \"Substrate selectivity determinants not defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined a negative regulator that blocks NEMO oligomerization, with N4BP1 binding the COZI domain and caspase-8 cleavage relieving inhibition during TLR signaling.\",\n      \"evidence\": \"Co-IP, domain mapping, in vitro binding, caspase-8 cleavage, and N4bp1 KO mice\",\n      \"pmids\": [\"33654074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of dimerization blockade not solved\", \"Breadth across TLR/receptor inputs not fully mapped\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Unified the ubiquitin-sensing model by showing polyubiquitin chains drive NEMO liquid-liquid phase separation that is required for IKK/NF-κB activation and impaired by disease mutations.\",\n      \"evidence\": \"In vitro reconstitution with purified proteins, cell-based phase separation, and disease/domain mutant analysis\",\n      \"pmids\": [\"35477005\", \"36720498\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative link between condensate properties and IKK output incomplete\", \"In vivo relevance of condensates not demonstrated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated isoform-specific signal routing, showing exon 5 is required for NEMO-TBK1 association and proper type I IFN versus NF-κB partitioning.\",\n      \"evidence\": \"Patient-derived cells, NEMO-Δex5 co-IP with TBK1, and pathway-selective stimulation assays\",\n      \"pmids\": [\"35289316\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of exon-5-dependent TBK1 binding unknown\", \"Single-lab patient-derived system\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extended NEMO function beyond canonical signaling to organelle damage sensing and protein quality control, via Parkin-dependent recruitment to mitochondria and p62 co-condensation for aggregate autophagy.\",\n      \"evidence\": \"Live imaging, FRAP, Parkin KO, in vitro phase transition reconstitution, and patient cell analysis\",\n      \"pmids\": [\"37683611\", \"38114471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signal that recruits NEMO to mitochondria/aggregates not fully defined\", \"Relative contribution of NF-κB-independent roles in vivo unclear\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the diverse NEMO post-translational modifications, conformational states, and condensate properties are integrated to set quantitative IKK output across distinct receptor inputs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic structure of the activated, ubiquitin-engaged full-length complex\", \"No unified quantitative model linking PTM combinations to signaling outcome\", \"In vivo relevance of phase separation not directly tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 8, 26]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [13, 23]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [19, 23]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 8]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [16, 17, 24]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [6, 14]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [22, 29]}\n    ],\n    \"complexes\": [\"IKK complex\"],\n    \"partners\": [\"IKBKB\", \"CHUK\", \"RIPK1\", \"ELKS\", \"SQSTM1\", \"TBK1\", \"MARCH2\", \"N4BP1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}